TY - GEN AU - Xin Yang AU - Yifei Wang AU - Ryan Byrne AU - Gisbert Schneider AU - Shengyong Yang TI - Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery PY - 2019/// CY - [Place of publication not identified] PB - American Chemical Society KW - artificial intelligence in drug discovery KW - deep learning KW - virtual screening KW - ligand-based virtual screening KW - structure-based virtual screening KW - de novo drug design KW - B. Sc. Artificial Intelligence KW - UMUN open access collection KW - artificial intelligence KW - Review articles N1 - Publication type: Review article; Linked open-access copy: published version; Open access; no subscription required for the linked open-access version N2 - Artificial intelligence (AI), and, in particular, deep learning as a subcategory of AI, provides opportunities for the discovery and development of innovative drugs. Various machine learning approaches have recently (re)emerged, some of which may be considered instances of domain-specific AI which have been successfully employed for drug discovery and design. This review provides a comprehensive portrayal of these machine learning techniques and of their applications in medicinal chemistry. After introducing the basic principles, alongside some application notes, of the various machine learning algorithms, the current state-of-the art of AI-assisted pharmaceutical discovery is discussed, including applications in structure- and ligand-based virtual screening, de novo drug design, physicochemical and pharmacokinetic property prediction, drug repurposing, and related aspects. Finally, several challenges and limitations of the current methods are summarized, with a view to potential future directions for AI-assisted drug discovery and design UR - https://doi.org/10.1021/acs.chemrev.8b00728 ER -